Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-07-14

Clinical Trial Update: Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas [Phase 4]

View source ↗

Summary

Phase 4 trial assessing cytokine-induced killer cells for advanced malignant gliomas; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cytokine-induced killer cells

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Cytokine-Induced Killer Cells, Advanced Milignant Gliomas | Phase 4 | Status: NOT_YET_RECRUITING